Heterophilic antibodies produce spuriously elevated concentrations of the MB isoenzyme of creatine kinase in a selected patient population

American Journal of Clinical Pathology

Volumn 107, Issue 5, 1997, Pages 506-510

  Sosolik, Randolph C ^a   Hitchcock, Charles L ^a   Becker, William J ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Dual site sandwich immunoassay; Heterophile antibodies; Human anti murine antibodies; MB isoenzyme of creatine kinase

Indexed keywords

CREATINE KINASE MB; HETEROPHILE ANTIBODY; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY I 125; REAGENT; TUMOR ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOASSAY; METASTASIS; PATIENT SELECTION; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0030892115     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/107.5.506     Document Type: Article

References (23)

1. Roberts R, Gowda KS, Lubrook PA, et al. Specificity of serum MB creatine phosphokinase activity in the diagnosis of acute myocardial infarction. Am J Cardiol. 1975;36:433-437.
2. Lott JA, Stang JM. Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis. Clin Chem. 1980;26:1241-1250.
3. Marmon A, Alpan G, Keidor S, et al. The MB isoenzyme of creatine kinase as an indicator of severity of myocardial ischemia. Lancet. 1978;2:812-814.
4. Thompson RJ, Jackson AP, Langlois N. Circulating antibodies to mouse monoclonal immunoglobulins in normal subjects: Incidence, species specificity and effects in a two-site assay for creatine kinase-MB isoenzyme. Clin Chem. 1986;32:476-481.
5. Kricka LJ, Schmerfeld-Pruss D, Senior M, et al. Interference by human anti-mouse antibody in two-site immunoassays. Clin Chem. 1990;36:892-894.
6. Primus FJ, Kelley EA, Hanson HJ, et al. "Sandwich"-type immunoassay of carcinoembryonic antigens in patients receiving murine monoclonal antibodies for diagnosis and therapy. Clin Chem. 1988;34:261-264.
7. Levinson SS. Antibody multispecificity in immunoassay interference. Clin Biochem. 1992;25:77-87.
8. Courtney-Luck NS, Epenetos AA, Winearls CG, et al. Pre-existing human anti-murine immunoglobulin reactivity due to polyclonal rheumatoid factors. Cancer Res. 1987;47:4520-4525.
9. Price T, Beatty BG, Beatty JD, et al. Human anti-murine antibody interference in measurement of carcinoembryonic antigen assessed with a double-antibody enzyme immunoassay. Clin Chem. 1991;37:51-57.
10. Boscato LM, Stuart MC. Heterophilic antibodies: a problem for all immunoassays. Clin Chem. 1988;34:27-33.
11. Hansen HJ, Sullivan CL, Sharkey RM, et al. HAMA interference with murine monoclonal antibody-based immunoassays. J Clin Immunoassay. 1993;16:294-299.
12. Hinkle HG, Mojzisik CM, Loesch JA, et al. The evolution of the radio-immunoguided surgery system. Antibody Immunoconjugates Radiopharmaceuticals. 1991;4:339-358.
13. Kim JA, Triozzi PL, Martin EW Jr. Radioimmunoguided surgery for colorectal cancer. Oncology. 1993;7:55-64.
14. Schroff RW, Foon KA, Beatty SM, et al. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res. 1985;45:879-885.
15. Sears HF, Herlyn D, Steplewski Z, et al. Effects of monoclonal antibody immunotherapy on patients with gastrointestinal adenocarcinoma. J Biol Resp Mod. 1984;3:138-150.
16. Doerr RJ, Abdel-Nabi H, Krag D, et al E. Radiolabeled antibody imaging in the management of colorectal cancer: results of a multicenter study. Ann Surg. 1991;214:118-124.
17. Kaladas PM, Khazaeli MB, Hazzard E, et al. Detection of human anti-murine antibody (HAMA) following infusion of Oncoscint CR103: comparison of Immunostrip ELISA with a double antigen radiometric assay. Antibod Immunoconj Radiopharm. 1991;4:309-317.
18. Reynolds JC, Del Vecchio S, Sakahara H, et al. Anti-murine antibody response to mouse monoclonal antibodies: clinical findings and implications. Nucl Med Biol. 1989;16:121-125.
19. Hansen HJ, Lafontaine G, Newman ES, et al. Solving the problem of antibody interference in commercial "sandwich"-type immunoassays of carcinoembryonic antigen. Clin Chem. 1989;35:146-150.
20. 2 conjugate and polyclonal IgG. Clin Chem. 1992;38:1737-1742.
21. Reinsberg J. Different efficacy of various blocking reagents to eliminate interferences by human antimouse antibodies with a two-site immunoassay. Clin Biochem. 1996;29:145-148.
22. Maita PK, Lang GM, Sehon AH. Tolerogenic conjugates of xenogeneic monoclonal antibodies with monomethoxypolyethylene glycol, I: induction of long-lasting tolerance to xenogeneic monoclonal antibodies. Int J Cancer. 1988;3(suppl):17-22.
23. Newman ES, Moskie LA, Duggal RN, et al. Murine monoclonal antibody adsorbed onto vinylidene fluoride floccules used to eliminate antibody interference in "sandwich"-type immunoassays. Clin Chem. 1989;35:1743-1746.